Skip to main content
Signal8

Sol-Gel Technologies Ltd. (SLGL)

Sol-Gel Technologies Ltd., a pharmaceutical firm currently in its clinical development phase, specializes in the creation and market introduction of skin-applied medications. These products leverage the company's distinctive microencapsulation technology, with their primary development and commercialization activities centered in Israel. Sol-Gel's pipeline features several key candidates. Twyneo, an innovative, non-antibiotic topical cream designed for once-daily application, has successfully concluded Phase III trials for treating acne vulgaris. Similarly, Epsolay, another topical cream administered once a day, has also completed its Phase III studies, targeting papulopustular rosacea. Advancing through Phase I clinical trials is SGT-210, intended for palmoplantar keratoderma. Furthermore, the company is investigating Erlotinib, Tapinarof, and Roflumilast as potential treatments for psoriasis and various other medical conditions. Beyond its proprietary offerings, the company also engages in creating generic versions of topical dermatological medications. Sol-Gel Technologies maintains a strategic partnership with Perrigo. Established in 1997, the company maintains its headquarters in Ness Ziona, Israel.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Sol-Gel Technologies Ltd. logo

Sol-Gel Technologies Ltd.

NASDAQ:SLGLHealthcare
-0.45%$68.35
AH$68.35+0.00%vs close
Mkt Cap$223.78M
Float1.52M
O/S3.27M
Vol
$ Vol
RVOL
Inst Own40.4%
SI9.0%
Earnings
Dilution
Financials Summary
Revenue$19.39M
Net Income-$6.13M
Total Assets$29.92M
Free Cash Flow$275K
Debt & Equity
Debt 4%
Equity 96%
Total Debt$991K
Total Equity$22.81M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
2-year cumulative
1:10

Nasdaq bars a compliance period at 1:250

  1. 1:10Reverse split
    May 5, 202510 shares → 1
Balance Sheet Details
Assets$29.92M
Liabilities$7.11M
Accounts Receivable$1.97M
Accounts Payable$735K
Inventory$0
PP&E (Net)$1.17M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue$19.39M$11.54M$1.55M$3.88M$31.27M$8.77M$22.9M$129K$174K$0$0$0
YoY Growth68.0%642.5%-60.0%-87.6%256.5%-61.7%17655.0%-25.9%----
Cost of Revenue$0$0$0$12.68M$20.38M$27.91M$40.58M$28.15M$300K$359K$300K$0
Gross Profit$19.39M$11.54M$1.55M-$8.8M$10.89M-$19.14M-$17.67M-$28.02M-$126K-$359K-$300K$0
Gross Margin100.0%100.0%100.0%-226.6%34.8%-218.2%-77.2%-21718.6%-72.4%---
Research and Development$22.8M$17.8M$23.54M$12.68M$20.38M$27.91M$40.58M$28.15M$25.8M$17.02M$7.18M$2.93M
Selling, General, and Administrative$4.18M$5.75M$7.37M$7.45M$8.45M$11.09M$8.28M$5.5M$6M$3.73M$2.46M$1.88M
Other-$54K$0-$55K-$12.68M-$20.91M-$27.91M$0$0$0$0$0$0
Total Operating Expenses$26.93M$23.55M$30.86M$7.45M$7.93M$11.09M$48.85M$33.65M$31.81M$20.76M$9.65M$4.81M
Operating Income (EBIT)-$7.54M-$12.01M-$29.3M-$16.24M$2.96M-$30.23M$25.95M-$33.52M-$31.63M-$20.76M-$9.65M-$4.81M
Operating Margin-38.9%-104.1%-1885.8%-418.3%9.5%-344.7%113.3%-25985.3%-18179.9%---
Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
Interest Income$1.41M$1.43M$2.07M$1.32M$257K$943K$1.37M$1.32M$65K$0$0$40K
Other Income (Expense)$1.41M$1.43M$2.07M$1.32M$257K$943K$1.37M$1.32M$65K-$15K-$13K-$40K
Income Before Tax (EBT)-$6.13M-$10.58M-$27.24M-$14.92M$3.22M-$29.29M-$24.58M-$32.2M-$31.57M-$20.77M-$9.66M-$4.85M
Income Tax Expense$0$0$0$0$0$0$33K$0-$65K$15K$13K$0
Net Income-$6.13M-$10.58M-$27.24M-$14.92M$3.22M-$29.29M-$24.61M-$32.2M-$31.57M-$20.77M-$9.66M-$4.85M
Net Income Margin-31.6%-91.7%-1752.8%-384.3%10.3%-333.9%-107.4%-24963.6%-18142.5%---
Supplementary Data
EPS-2.20-3.79-10.01-0.651.40-1.30-1.26-1.80-1.76-1.77-0.82-1.81
Diluted EPS-2.20-3.79-10.01-0.650.14-1.30-1.26-1.80-1.76-1.77-0.82-1.81
Weighted Average OS2.79M2.79M2.71M23.13M23.06M22.57M19.53M17.87M17.99M11.74M11.74M2.68M
EBITDA-$7.43M-$11.78M-$28.96M-$15.68M$3.84M-$29.29M-$25.06M-$32.76M-$31.16M-$20.4M-$9.35M-$4.58M
EBITDA Margin-38.3%-102.1%-1863.8%-403.9%12.3%-333.9%-109.4%-25394.6%-17909.2%---
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Assets
Current Assets
Cash and Cash Equivalents$11.03M$19.49M$7.51M$12.45M$20.09M$7.12M$9.41M$5.33M$5.02M$7M$5.89M$594K
Short-Term Investments$12.97M$4.44M$30.48M$21.18M$23.16M$43.05M$40.97M$57.66M$4M$0$0$0
Cash and Short-Term Investments$24M$23.93M$38M$33.63M$43.24M$50.17M$50.38M$62.99M$9.02M$7M$5.89M$594K
Accounts Receivable$1.97M$3.6M$377K$7.92M$13.06M$2.15M$4.12M$0$0$0$0$0
Inventory$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Assets$1M$3.77M$2.79M$0$0$0$0$0$0$472K$244K$0
Total Current Assets$26.97M$31.3M$41.17M$43.05M$57.11M$53.4M$55.79M$65.97M$10.55M$8.3M$6.14M$839K
Long-Term Assets
Property, Plant & Equipment Net$1.17M$1.63M$2.15M$1.54M$2.55M$3.71M$4.35M$2.6M$2.31M$798K$785K$771K
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$1.32M$2.31M$1.28M$1.29M$8.7M$0$472K$0$1.77M$0$92K$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$455K$608K$681K$749K$830K$2.05M$684K$1.1M$680K$1.89M$1.23M$776K
Total Long-Term Assets$2.95M$4.55M$4.12M$3.57M$12.08M$5.76M$5.51M$3.71M$4.77M$2.69M$2.1M$1.55M
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$29.92M$35.85M$45.29M$46.63M$69.19M$59.16M$61.3M$69.68M$15.31M$10.98M$8.24M$2.39M
Liabilities
Current Liabilities
Accounts Payable$735K$1.26M$154K$251K$766K$1.2M$1.71M$2.92M$534K$667K$311K$247K
Short-Term Debt$495K$0$0$0$0$0$0$0$65.34M$37.34M$17.34M$3.33M
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Liabilities$4.49M$0$0$0$0$0$0$0$0$0$0$0
Total Current Liabilities$6.17M$5.29M$4.52M$3.33M$11.69M$5.96M$6.5M$4.89M$67.2M$41.63M$19.14M$4.66M
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$439K$833K$915K$1.03M$1.09M$1.05M$958K$878K$810K$694K$626K$0
Total Long-Term Liabilities$935K$1.71M$2.12M$1.09M$1.9M$2.35M$2.33M$878K$810K$694K$626K$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$7.11M$7M$6.64M$4.42M$13.6M$8.31M$8.84M$5.77M$68.01M$42.32M$19.76M$4.66M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$774K$774K$774K$638K$638K$635K$561K$520K$82K$82K$82K$82K
Retained Earnings-$237.01M-$230.88M-$220.3M-$193.06M-$178.14M-$181.36M-$152.07M-$127.46M-$95.26M-$63.69M-$42.92M-$33.26M
Comprehensive Income & Other$0$0$0$0$0$0$0$0-$1.98M-$1.51M-$1.15M$0
Other Stockholders' Equity$259.05M$258.96M$258.17M$234.64M$233.1M$231.58M$203.98M$190.85M$42.48M$32.27M$31.32M$30.19M
Total Equity$22.81M$28.85M$38.64M$42.21M$55.59M$50.85M$52.47M$63.91M-$52.7M-$31.34M-$11.52M-$2.99M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$29.92M$35.85M$45.29M$46.63M$69.19M$59.16M$61.3M$69.68M$15.31M$10.98M$8.24M$1.67M
Supplementary Data
Total Debt$991K$1.31M$1.65M$772K$1.59M$1.97M$2.04M$0$65.34M$37.34M$17.34M$3.33M
Net Debt-$10.04M-$18.18M-$5.86M-$11.68M-$18.49M-$5.15M-$7.37M-$5.33M$60.31M$30.34M$11.44M$2.74M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Operating Activities
Net Income-$6.13M-$10.58M-$27.24M-$14.92M$3.22M-$29.29M-$24.61M-$32.2M-$31.57M-$20.77M-$9.66M-$4.85M
Depreciation & Amortization$109K$233K$342K$562K$880K$946K$887K$762K$471K$359K$300K$225K
Deferred Income Tax$0$0$0$0-$96K$138K$65K$29K$0$0$0$0
Stock-Based Compensation$0$786K$1.86M$1.53M$687K$1.22M$2.55M$4.65M$3.97M$952K$1.13M$0
Changes in Working Capital:
  Accounts Receivable$1.63M-$4.2M$7.54M$12.55M-$18.31M$1.97M-$4.12M$0$0$0$0$0
  Inventory$0$0$0$0$0$0$1.69M$0$0$0$0$0
  Accounts Payable$820K$780K$1.47M-$8.3M$5.62M-$542K$938K$3.03M-$2.49M$2.5M$449K$0
  Other Working Capital$3.75M-$981K-$1.34M-$709K$274K$219K$0-$1.36M-$199K-$358K-$710K-$141K
Total Working Capital Change$6.19M-$4.4M$7.67M$3.54M-$12.44M$1.64M-$1.45M$3.33M-$3.15M$957K-$261K-$141K
Other Non-Cash Items$148K$74K-$361K-$188K$55K$104K$50K-$5K$6.18M$8K$448K-$66K
Net Cash from Operating$322K-$13.89M-$17.73M-$9.48M-$7.69M-$25.24M-$22.5M-$23.47M-$24.09M-$18.5M-$8.04M-$4.83M
Investing Activities
Capital Expenditures-$47K-$2K-$134K-$171K-$143K-$449K-$597K-$1.05M-$1.93M-$385K-$291K-$268K
Acquisitions$54K$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments-$14.08M$0-$23.98M-$10.01M-$6.76M-$53.72M-$38.7M-$71.78M-$4.01M-$15K-$8K$0
Sales of Investments$5.51M$26.69M$14.29M$11.88M$26.78M$51.5M$55.33M$18.09M$0$0$0$0
Other Investing Activities-$20K$6K$74K$0-$5K-$21K-$10K$8K-$4.01M$9K$89K$1.17M
Net Cash from Investing-$8.58M$26.69M-$9.74M$1.7M$19.87M-$2.69M$16.02M-$54.73M-$5.94M-$391K-$210K$897K
Financing Activities
Debt Repaid------------
Common Stock Issuance$6K$0$21.54M$15K$505K$26.31M$10.61M$78.78M$0$0$0$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$0$268K$0$332K$151K$0$44K$0$0$0$3.33M
Net Cash from Financing$6K$0$21.81M$15K$837K$26.46M$10.61M$78.82M$28M$20M$13.57M$3.33M
Forex Effect-$204K-$1K-$73K$133K-$55K-$12K-$50K$34K$50K-$8K-$17K-$74K
Net Change in Cash-$8.46M$12.8M-$5.74M-$7.64M$12.96M-$1.49M$4.09M$651K-$1.98M$1.11M$5.3M-$672K
Supplementary Data
Operating Cash Flow$322K-$13.89M-$17.73M-$9.48M-$7.69M-$25.24M-$22.5M-$23.47M-$24.09M-$18.5M-$8.04M-$4.83M
Capital Expenditure-$47K-$2K-$134K-$171K-$143K-$449K-$597K-$1.05M-$1.93M-$385K-$291K-$268K
Free Cash Flow$275K-$13.89M-$17.86M-$9.65M-$7.83M-$25.69M-$23.1M-$24.52M-$26.01M-$18.88M-$8.34M-$5.1M
Cash at Beginning$19.49M$7.86M$13.6M$21.23M$8.27M$9.76M$5.67M$5.02M$7M$5.89M$594K$1.27M
Cash at End$11.03M$20.66M$7.86M$13.6M$21.23M$8.27M$9.76M$5.67M$5.02M$7M$5.89M$594K